Bullous pemphigoid receiving a novel long‐acting dipeptidyl‐peptidase‐4 (DPP‐4) inhibitor omarigliptin in a patient with type 2 diabetes: A case report

• Hiroshi Kasamatsu,
• Takenao Chino,
• Noritaka Oyama,
• Takakiyo Nakaya,
• Minoru Hasegawa

Affiliations

Hiroshi Kasamatsu

Department of Dermatology Tannan Regional Medical Center Fukui Japan

Takenao Chino

Department of Dermatology Faculty of Medical Sciences University of Fukui Fukui Japan

Noritaka Oyama

Department of Dermatology Faculty of Medical Sciences University of Fukui Fukui Japan

Takakiyo Nakaya

Department of Internal Medicine Tannan Regional Medical Center Fukui Japan

Minoru Hasegawa

Department of Dermatology Faculty of Medical Sciences University of Fukui Fukui Japan